A Multiple-Ascending-Dose Study of MK-1708 in Healthy Participants
MK-1708-002
Phase 1 other active
Quick answer
A Multiple-Ascending-Dose Study of MK-1708 in Healthy Participants for Amyotrophic lateral sclerosis and Alzheimer’s disease is a Phase 1 program (other) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck Sharp and Dohme
- Indication
- Amyotrophic lateral sclerosis and Alzheimer’s disease
- Phase
- Phase 1
- Modality
- other
- Status
- active